the First Affiliated Hospital with Nanjing Medical University
the First Affiliated Hospital with Nanjing Medical University
Nanjing, Jiangsu, China17 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Intra-arterial Thrombolysis For Acute Ischemic Stroke With Medium Vessel Occlusion | Acute Ischemic Stroke, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Phase 3 | 2026-09-23 | NCT07668323 | |
| Safety and Efficacy of Esketamine - Dexmedetomidine Combination Versus Dexmedetomidine Monotherapy for Hyperactive Delirium in ICU Patients on Non-Invasive Respiratory Support (SEED-NIRS Trial): Study Protocol of a Randomized Controlled Trial | Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, agnosia, nervous system disorder, perceptual disorders | Not yet recruiting | Phase 4 | 2026-09-03 | NCT07377981 | |
| A Study on the Treatment of CTIT of the Efficacy and Safety With Romiplostim N01 Compared to Recombinant Human Interleukin-11 | CTIT: Cancer Therapy Induced Thrombocytopenia | Recruiting | Phase 3 | 2026-04-14 | NCT06759636 | |
| Disitamab Vedotin Combined With SOX Regimen Versus SOX Alone as Adjuvant Therapy for HER2-Moderate/High Expressing Stage Ⅲ Gastric Cancer: A Prospective, Multicenter, Randomized, Phase Ⅱ Clinical Trial | GC/GEJC | Recruiting | Phase 2 | 2026-03-16 | NCT07474324 | |
| A Clinical Study of Inhaled Nitric Oxide in Patients With Chronic Obstructive Pulmonary Disease | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Not applicable | 2026-02-02 | NCT07382258 | |
| SHR2554 as Maintenance Therapy in Patients With Peripheral T-cell Lymphoma | mature T-cell and NK-cell non-Hodgkin lymphoma | Not yet recruiting | Phase 2 | 2026-01-16 | NCT07347288 | |
| The Efficacy and Safety of Glofitamab in Combination With PD-1 Antibody and Lenalidomide in Patients With Relapsed/Refractory Large B-cell Lymphoma (LBCL) With TP53 Aberrations: A Prospective, Multicenter, Phase II Clinical Study | large B-cell lymphoma | Recruiting | Phase 2 | 2025-11-20 | NCT07240194 | |
| Brentuximab Vedotin Combined With R-CHP in Newly Diagnosed EBV+ DLBCL-NOS | Digestive System Diseases, Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly, digestive system disorder, hypertrophic pyloric stenosis, pyloric stenosis, stomach disorder | Not yet recruiting | Phase 2 | 2025-09-30 | NCT06925555 | |
| QL1706 With Olaparib for Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency (HRD) | Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency | Not yet recruiting | Phase 2 | 2025-08-11 | NCT07113964 | |
| A Clinical Study of Inhaled Nitric Oxide in Moderate-to-Severe Chronic Obstructive Pulmonary Disease | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Not applicable | 2025-06-18 | NCT05896800 | |
| Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, histiocytosis, interdigitating dendritic cell sarcoma, lymphatic system disorder, malignant histiocytosis, neoplasm | Recruiting | Phase 2 | 2025-03-24 | NCT06891157 | |
| Study on the Effect and Mechanism of Lupatadine Fumarate in the Treatment of Allergic Rhinitis | Hypersensitivity, Immediate, Respiratory Hypersensitivity, Rhinitis, Allergic, immune system disorder, nasal disorder, otorhinolaryngologic disease, respiratory system disorder, rhinitis | Recruiting | Not applicable | 2024-11-29 | NCT06709092 | |
| Mecapegfilgrastim Combined With Adebrelimab and Chemotherapy as Neoadjuvant Therapy in Resectable GC/GEJC | GC/GEJC | Not yet recruiting | Phase 2 | 2024-11-12 | NCT06684158 | |
| Clinical Study Protocol of IAV-induced Remission Followed by Consolidation Therapy With MDCyta+Ven in ND-AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Not applicable | 2024-01-31 | NCT06232694 | |
| A Phase 1 Study to Evaluate the Safety and Tolerability of TT-01488 in Patients With B-Cell Malignancies | B-Cell Malignancies | Recruiting | Phase 1 | 2023-11-21 | NCT05683717 | |
| Clinical Study Protocol of Maintenance Therapy With Venetoclax in Elderly Patients With AML in First Complete Remission | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Not applicable | 2023-06-18 | NCT05909293 | |
| Unrelated Umbilical Cord Blood Stem Cell Combined With Azacitidine Based Treatment for Advanced MDS,CMML-2 and sAML | Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bone marrow disorder, chronic myelomonocytic leukemia, hematologic disorder, leukemia, myelodysplastic syndrome, myelodysplastic/myeloproliferative disease, myeloid leukemia, neoplasm, therapy related acute myeloid leukemia and myelodysplastic syndrome | Recruiting | Phase 1 / Phase 2 | 2022-10-18 | NCT05584761 |